The growth is driven by expanding therapeutic applications beyond diabetes, such as obesity and cardiovascular diseases
GLP-1 and dual GIP/GLP-1 receptor agonists such as Wegovy, Ozempic, Saxenda, Mounjaro, and ZepBound work at the hormonal level to regulate appetite, slow gastric emptying, improve satiety, and stabilize blood sugar
It should not replace blood pressure medication unless a healthcare provider recommends that change
confirm at checkout What's included (brand-stated): medication, clinician visits, dose adjustments, portal messaging, free overnight shipping - no separate membership fee per brand disclosure Compounding status: Compounded semaglutide and tirzepatide are not FDA-approved finished drug products